Have a feature idea you'd love to see implemented?
Let us know!
ANNX Annexon Inc
Price (delayed)
$7.34
Market cap
$775.5M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.22
Enterprise value
$647.37M
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on
Highlights
Annexon's quick ratio has soared by 99% YoY and by 6% from the previous quarter
The equity has surged by 95% year-on-year and by 38% since the previous quarter
Key stats
What are the main financial stats of ANNX
Market
Valuations
Earnings
Shares outstanding
105.65M
Market cap
$775.5M
Enterprise value
$647.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$115.16M
EBITDA
-$111.8M
Free cash flow
-$101.77M
Per share
Balance sheet
Liquidity
EPS
-$1.22
Free cash flow per share
-$0.78
Book value per share
$3.91
Revenue per share
$0
TBVPS
$3.12
Total assets
$406.09M
Total liabilities
$45.01M
Debt
$30.2M
Equity
$361.08M
Working capital
$356.82M
Debt to equity
0.08
Current ratio
21.81
Quick ratio
21.56
Net debt/EBITDA
1.15
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-38%
Return on equity
-44.7%
Return on invested capital
-77%
Return on capital employed
-29.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANNX stock price
How has the Annexon stock price performed over time
Intraday
-3.04%
1 week
-3.67%
1 month
10.38%
1 year
336.9%
YTD
61.67%
QTD
23.99%
Financial performance
How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$126.94M
Net income
-$115.16M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 20% YoY and by 4.6% QoQ
The company's operating income rose by 16% YoY and by 3.1% QoQ
Growth
What is Annexon's growth rate over time
Valuation
What is Annexon stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 35% YoY and by 16% QoQ
The equity has surged by 95% year-on-year and by 38% since the previous quarter
The P/B is 39% higher than the last 4 quarters average of 1.4 and 14% higher than the 5-year quarterly average of 1.7
Efficiency
How efficient is Annexon business performance
The ROE is up by 30% year-on-year and by 21% since the previous quarter
The return on invested capital has grown by 28% year-on-year and by 25% since the previous quarter
ANNX's ROA is up by 27% YoY and by 18% QoQ
Dividends
What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANNX.
Financial health
How did Annexon financials performed over time
Annexon's quick ratio has soared by 99% YoY and by 6% from the previous quarter
Annexon's current ratio has soared by 98% YoY and by 6% from the previous quarter
Annexon's debt is 92% less than its equity
The equity has surged by 95% year-on-year and by 38% since the previous quarter
The debt to equity has dropped by 53% year-on-year and by 33% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.